Catalogue illustration · 5 mg
Research material
Semaglutide
Metabolic
3 mL pen · 5 mg
A GLP-1 receptor agonist: a 31-amino-acid analogue of human glucagon-like peptide-1, modified to resist enzymatic breakdown and bind albumin, which extends its half-life to about a week.
Supplied for laboratory research use only. Not for human or animal consumption. Price is per pen, EU delivery included.
- Total fill
- 5 mg
- Format
- 3 mL pen
- Material
- Research material
- Purpose
- Laboratory research
01 — The format
The catalogue format.
Semaglutide is listed as 5 mg in a 3 mL pre-filled pen. The listed quantity is total content per pen, not an administration dose.
The catalogue format does not establish concentration accuracy, stability or delivered volume. These require product-specific documentation.
No reconstitution, dosing or application instructions are supplied. Request the material specification and lot documentation for your laboratory review.
02 — The sequence
The sequence and its identity.
A GLP-1 receptor agonist: a 31-amino-acid analogue of human glucagon-like peptide-1, modified to resist enzymatic breakdown and bind albumin, which extends its half-life to about a week.
Reference sequence: Not available — a verified sequence for the supplied material has not been published.
The catalogue medicine category refers to the regulatory history of named medicines containing this ingredient. It does not establish approval of the Aevamere product, its formulation or any use.
A compound-specific primary-source review is not yet published here. The description above comes from the existing catalogue; it is not a batch certificate.
Reference, not verification. Reference descriptions concern the named compound. They do not verify the contents, purity, biological activity or safety of a supplied batch.
03 — Specification
Analytical data and documentation.
- Compound
- Semaglutide
- Catalogue fill
- 5 mg
- Format
- 3 mL pre-filled pen, as listed in the catalogue
- Reference sequence
- Not available — a verified sequence for the supplied material has not been published.
- Molecular formula / mass
- Not verified for the supplied form — request the product specification.
- Salt / counterion
- Not published for this product.
- Batch / lot
- Not available on this page.
- Measured purity
- Not available — no product-matched analytical report has been provided.
- Identity result
- Not available — reference identity is not a measured batch result.
- Endotoxin / sterility
- Not available — no product-matched results have been provided.
- Storage / expiry
- Consult the product-specific label and supporting stability documentation; not verified here.
04 — Batch documentation
Batch results not published.
No verified, product-matched batch report is available on this page. Purity, identity, endotoxin and sterility results are not inferred from the compound name or another product.
Chromatography and mass spectrometry are examples of analytical approaches. The appropriate methods depend on the material; naming a method is not evidence that testing was performed.
Request the specific lot and its supporting reports
Request documentation05 — Handling
Supplied as laboratory research material.
Semaglutide is sold for in-vitro and analytical research use. This page does not establish marketing authorisation and gives no usage, dosing or application guidance of any kind.
- For in-vitro and analytical laboratory research use only
- Not for human or animal consumption
- Not for clinical, diagnostic, therapeutic or cosmetic use
- Follow product-specific documentation and your laboratory procedures
- No dosing or administration guidance is provided
06 — What arrives
In the box.
- Catalogue format: one 3 mL pen · 5 mg.
- Confirm packaging, accessories and documentation with the supplier before ordering.
- Batch certificates, storage records and expiry documentation have not been published on this page.
07 — Questions
About this sequence specifically.
- What quantity does this page describe?
- 5 mg per 3 mL pen. This is a catalogue quantity, not dosing guidance.
- Is the sequence a batch test?
- Not available — a verified sequence for the supplied material has not been published.
- Where are the analytical results?
- No product-matched certificate is published here. Request the lot number, methods, results and acceptance criteria before evaluating the material.
- Does a medicine approval apply to this pen?
- The catalogue medicine category refers to the regulatory history of named medicines containing this ingredient. It does not establish approval of the Aevamere product, its formulation or any use.
The rest of the collection
Held to the same standard.
Accounts & bulk supply
Ask about this material.
For availability, product specifications, batch documentation or bulk quantities, tell us what your laboratory requires.